|
ATGP3646-250ug
|
NKMax Bio (ATGen)
|
Neprilysin [52-750 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3646-50ug
|
NKMax Bio (ATGen)
|
Neprilysin [52-750 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
HY-W039519-1g
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W039519-100mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W039519-25mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W039519-50mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-1mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-10mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-5mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-50mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-1mL
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1883A-1mg
|
MedChemexpress LLC
|
Bacterial Sortase Substrate III, Abz/DNP (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1883A-5mg
|
MedChemexpress LLC
|
Bacterial Sortase Substrate III, Abz/DNP (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13222-10mg
|
MedChemexpress LLC
|
BAN ORL 24 [CAS 1401463-54-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13222-100mg
|
MedChemexpress LLC
|
BAN ORL 24 [CAS 1401463-54-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13222-5mg
|
MedChemexpress LLC
|
BAN ORL 24 [CAS 1401463-54-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13222-50mg
|
MedChemexpress LLC
|
BAN ORL 24 [CAS 1401463-54-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13222-1mL
|
MedChemexpress LLC
|
BAN ORL 24 [CAS 1401463-54-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112080-10mg
|
MedChemexpress LLC
|
BAY-6035 [CAS 2247890-13-5]
|
|
Cancer-programmed cell death
|
|
|
HY-112080-100mg
|
MedChemexpress LLC
|
BAY-6035 [CAS 2247890-13-5]
|
|
Cancer-programmed cell death
|
|
|
HY-112080-25mg
|
MedChemexpress LLC
|
BAY-6035 [CAS 2247890-13-5]
|
|
Cancer-programmed cell death
|
|
|
HY-112080-5mg
|
MedChemexpress LLC
|
BAY-6035 [CAS 2247890-13-5]
|
|
Cancer-programmed cell death
|
|
|
HY-112080-50mg
|
MedChemexpress LLC
|
BAY-6035 [CAS 2247890-13-5]
|
|
Cancer-programmed cell death
|
|
|
HY-112080-1mL
|
MedChemexpress LLC
|
BAY-6035 [CAS 2247890-13-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P3143A-1mg
|
MedChemexpress LLC
|
BMSpep-57 (hydrochloride)
|
|
Cancer-programmed cell death
|
|
